C WorldWide Group Holding A S Sells 8,500 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

C WorldWide Group Holding A S lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 103,311 shares of the medical equipment provider’s stock after selling 8,500 shares during the quarter. Intuitive Surgical comprises 0.7% of C WorldWide Group Holding A S’s portfolio, making the stock its 20th biggest holding. C WorldWide Group Holding A S’s holdings in Intuitive Surgical were worth $53,924,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management raised its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC raised its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $591.79 on Monday. The stock has a market cap of $210.78 billion, a price-to-earnings ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The stock has a 50 day moving average price of $565.45 and a 200-day moving average price of $525.60. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. Jefferies Financial Group increased their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.